1. Effect of XPD and TP53 Gene Polymorphisms on the Risk of Platinum-Based Chemotherapy Induced Toxicity in Bangladeshi Lung Cancer Patients

Volume 22, Issue 12, December 2021, Pages 3809-3815

Tahsin Nairuz; Yearul Umme Bushra; Yearul Kabir

• View Article
• PDF 313.45 K

2. The Platelet to Lymphocyte and Neutrophil to Lymphocyte Ratios in Predicting Response to Platinum-based Chemotherapy for Epithelial Ovarian Cancer

Volume 22, Issue 5, May 2021, Pages 1561-1566

Gatot Nyarumenteng Adhipurnawan Winarno; Marihot Pasaribu; Herman Susanto; Aisyah Shofiatun Nisa; Ali Budi Harsono; Hariadi Yuseran; Dodi Suardi; Nurvita Trianasari

• View Article
• PDF 301.04 K

3. Meta-analysis of Excision Repair Cross-complementation Group 1 (ERCC1) Association with Response to Platinumbased Chemotherapy in Ovarian Cancer

Volume 14, Issue 12, December 2013, Pages 7203-7206

• View Article
• PDF 438.77 K

4. DNA Repair Gene Associated with Clinical Outcome ofEpithelial Ovarian Cancer Treated with Platinum-basedChemotherapy

Volume 14, Issue 2, February 2013, Pages 941-946

• View Article
• PDF 473.88 K

5. Prognostic Significance of Hemoglobin Levels in Patients with Primary Epithelial Ovarian Carcinoma Undergoing Platinumbased Chemotherapy

Volume 12, Issue 1, January 2011, Pages 131-136

• View Article
• PDF 370.45 K